Proteomics International Laboratories Ltd.ASX: PIQ

Update on commercialisation of PromarkerD in the USA

· Issued by Proteomics International Laboratories Ltd.

Filed with ASX · · 2 pages · English

Summary by 6ix AI

This allows Proteomics International to pursue alternative licensing options and direct consumer sales for PromarkerD in the US market. The PromarkerD assay has been established in a CLIA certified laboratory in the USA, preparing for its launch.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Proteomics International Laboratories Ltd. on 6ix

Story so far

Earlier from Proteomics International Laboratories

Later from Proteomics International Laboratories

All Proteomics International Laboratories news releases